Skip to content
10-Q

Quarterly Report

Inhibitor Therapeutics, Inc. INTI

0001641172-25-023465

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 13, 2025 172.57M sh
Stock Issued Q2 2025 · Jun 30, 2025 215K sh
Stock Issued Q2 2025 · Jun 30, 2024 290K sh
Shares Diluted Q2 2025 · Jun 30, 2025 172.57M sh
Shares Diluted Q2 2025 · Jun 30, 2025 172.45M sh
Shares Diluted Q2 2025 · Jun 30, 2024 172.32M sh
Shares Diluted Q2 2025 · Jun 30, 2024 172.2M sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$1.87M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$1.74M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $3.74M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $5.61M
Stockholders Equity Q2 2025 · Jun 30, 2025 $715.64K
Stockholders Equity Q2 2025 · Mar 31, 2025 $1.35M
Stockholders Equity Q2 2025 · Dec 31, 2024 $1.99M
Stockholders Equity Q2 2025 · Jun 30, 2024 $4.14M
Stockholders Equity Q2 2025 · Mar 31, 2024 $4.64M
Stockholders Equity Q2 2025 · Dec 31, 2023 $5.28M
Current Liabilities Q2 2025 · Jun 30, 2025 $139.96K
Current Liabilities Q2 2025 · Dec 31, 2024 $709.62K
Total Liabilities Q2 2025 · Jun 30, 2025 $3.19M
Total Liabilities Q2 2025 · Dec 31, 2024 $3.71M
Current Assets Q2 2025 · Jun 30, 2025 $3.83M
Current Assets Q2 2025 · Dec 31, 2024 $5.69M
Total Assets Q2 2025 · Jun 30, 2025 $3.91M
Total Assets Q2 2025 · Dec 31, 2024 $5.69M
Eps Diluted Q2 2025 · Jun 30, 2025 $0.00
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.01
Eps Diluted Q2 2025 · Jun 30, 2024 $0.00
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.01
Eps Basic Q2 2025 · Jun 30, 2025 $0.00
Eps Basic Q2 2025 · Jun 30, 2025 −$0.01
Eps Basic Q2 2025 · Jun 30, 2024 $0.00
Eps Basic Q2 2025 · Jun 30, 2024 −$0.01
Sga Expense Q2 2025 · Jun 30, 2025 $370.15K
Sga Expense Q2 2025 · Jun 30, 2025 $808.64K
Sga Expense Q2 2025 · Jun 30, 2024 $345.37K
Sga Expense restated Q2 2025 · Jun 30, 2024 $859.83K
Rd Expense Q2 2025 · Jun 30, 2025 $325.62K
Rd Expense Q2 2025 · Jun 30, 2025 $561.68K
Rd Expense Q2 2025 · Jun 30, 2024 $239.78K
Rd Expense restated Q2 2025 · Jun 30, 2024 $500.14K
Net Income Q2 2025 · Jun 30, 2025 −$659.94K
Net Income Q2 2025 · Jun 30, 2025 −$1.29M
Net Income Q2 2025 · Mar 31, 2025 −$632.85K
Net Income Q2 2025 · Jun 30, 2024 −$501.69K
Net Income Q2 2025 · Jun 30, 2024 −$1.19M
Net Income Q2 2025 · Mar 31, 2024 −$684.71K
Operating Income Q2 2025 · Jun 30, 2025 −$695.77K
Operating Income Q2 2025 · Jun 30, 2025 −$1.37M
Operating Income Q2 2025 · Jun 30, 2024 −$585.15K
Operating Income Q2 2025 · Jun 30, 2024 −$1.36M